摘要
将人类免疫缺陷病毒(HIV)感染者与同年龄的健康人进行比较,人类免疫缺陷病毒(HIV)感染者有更高的患病感染率。复杂的艾滋病毒引起的免疫抑制,慢性抗原刺激,以及致癌病毒共同感染之间的关系,可能会促进肿瘤的发生,并增加这些患者肿瘤发展的风险。艾滋病感染者的癌症包括艾滋病定义恶性肿瘤(ADMS)和其他非艾滋病定义恶性肿瘤(NADMs)。抗逆转录病毒疗法减少了ADMs 的发病率,在过去几年中观察到,同时增加了NADMs的发生率。生物标志物是可测量的参数,表征了正常或致病的过程,它具有高潜能去进行患者的风险评估和诊断。因此,艾滋病毒阳性患者的癌症生物标志物早期检测将十分有用以确定患者在大多数肿瘤疾病发展中的风险。本次审查将重点集中于艾滋病的恶性肿瘤生物标志物上,细胞和病毒生物标志物,包括细胞因子,免疫激活分子和遗传多态性的几个生物标志物的风险评估和诊断的作用。
关键词: 艾滋病恶性肿瘤;肿瘤标志物;癌症艾滋病病毒;霍奇金淋巴瘤;非艾滋病恶性肿瘤;非霍奇金淋巴瘤。
Current Medicinal Chemistry
Title:The Role of Cancer Biomarkers in HIV Infected Hosts
Volume: 23 Issue: 22
Author(s): Domenico Galati, Serena Zanotta
Affiliation:
关键词: 艾滋病恶性肿瘤;肿瘤标志物;癌症艾滋病病毒;霍奇金淋巴瘤;非艾滋病恶性肿瘤;非霍奇金淋巴瘤。
摘要: A higher incidence of cancer has been observed in Human Immunodeficiency Virus (HIV) infected individuals as compared with healthy people of the same age. A complex relationship between HIV-induced immune suppression, chronic antigenic stimulation, and oncogenic virus co-infections may promote carcinogenesis and increase the risk of developing tumors in these patients. Cancers in HIV subjects include the AIDS-defining malignancies (ADMs) and other non-AIDS-defining malignancies (NADMs). Antiretroviral therapy has reduced the incidence of ADMs whereas a concurrent increase of NADMs was observed in the last years. Biomarkers are measurable parameters, characterizing normal or pathogenic processes, which could provide a high potential for risk evaluation and diagnosis of patients. Therefore, the early detection of cancer biomarkers in HIV-positive subjects would be useful to identify patients at most risk of tumor disease development.
This review will focus principally on the risk assessment and diagnostic role of several biomarkers of malignancy in HIV patients including cellular and viral biomarkers, cytokines, immune activation molecules and genetic polymorphisms.
Export Options
About this article
Cite this article as:
Domenico Galati, Serena Zanotta , The Role of Cancer Biomarkers in HIV Infected Hosts, Current Medicinal Chemistry 2016; 23 (22) . https://dx.doi.org/10.2174/0929867323666160530145102
DOI https://dx.doi.org/10.2174/0929867323666160530145102 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bcl-2 Antisense in the Treatment of Human Malignancies: A Delusion in Targeted Therapy
Current Pharmaceutical Biotechnology Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis
Cardiovascular & Hematological Disorders-Drug Targets Development of Aptamer-Based Nanomaterials for Biological Analysis
Current Molecular Medicine HIV-1 Infection: Recent Developments in Treatment and Current Management Strategies
Anti-Infective Agents in Medicinal Chemistry The Effects of Cantharidin and Cantharidin Derivates on Tumour Cells
Anti-Cancer Agents in Medicinal Chemistry Janus Kinase Inhibition with Tofacitinib: Changing the Face of Inflammatory Bowel Disease Treatment
Current Drug Targets CD47 Functionalization of Nanoparticles as a Poly(ethylene glycol) Alternative: A Novel Approach to Improve Drug Delivery
Current Drug Targets Targets for Anti-metastatic Drug Development
Current Pharmaceutical Design Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
Central Nervous System Agents in Medicinal Chemistry Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Human Platelet Acetylcholinesterase Inhibition by Cyclophosphamide: A Combined Experimental and Computational Approach
CNS & Neurological Disorders - Drug Targets Chemosensitization and Immunosensitization of Resistant Cancer Cells to Apoptosis and Inhibition of Metastasis by the Specific NF-κB Inhibitor DHMEQ
Current Pharmaceutical Design TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Current Pharmaceutical Design IL-10 Producing Regulatory B Cells in Mice and Humans: State of the Art
Current Molecular Medicine Prospects and Limitations of T Cell Receptor Gene Therapy
Current Gene Therapy Mechanisms Involved in Apoptosis Events Contributing to Sepsis-Induced Myocardial Dysfunction
Current Drug Therapy Glioblastoma Multiforme and its Cell Interruption
Current Cancer Therapy Reviews Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A Review
Current Medicinal Chemistry The N-Terminal Region of HIV-1 Tat Protein Binds CD127 in Human CD8 T Cells to Target the Receptor for Down Regulation Through Tat's Basic Region
Current HIV Research